logo

Mesoblast Limited (MESO)



Trade MESO now with
  Date
  Headline
11/11/2020 6:07:24 AM Mesoblast: Second Interim Analysis Of Outcomes Results In Recommendation To Continue Remestemcel-L Phase 3 Trial
10/13/2020 6:03:46 AM Mesoblast Says Phase 3 Trial Of Remestemcel-L Surpassed 50% Enrollment
9/2/2020 6:10:13 AM Mesoblast Secures Ethics Approval To Treat COVID-19 Patients In Australia
8/11/2020 9:53:24 AM Stock Alert: Mesoblast Tanks 30%
5/6/2020 6:09:51 AM Mesoblast Says First Patients Dosed In Phase 2/3 Randomized Controlled Trial Of Remestemcel-l